New England Journal of Medicine publishes initial data from TAILORx breast cancer trial

(ECOG-ACRIN Cancer Research Group) Initial results announced today from the Trial Assigning IndividuaLized Options for Treatment (Rx), or TAILORx, a prospectively conducted global trial in 10,000+ women with early stage breast cancer, found that 1,626 trial participants with low Oncotype DX® Recurrence Score® results (≤ 10) who got hormonal therapy alone without chemotherapy had
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news